MarianneGav (Talk | contribs) |
MarianneGav (Talk | contribs) |
||
Line 76: | Line 76: | ||
</h3> | </h3> | ||
<h4>A simple explanation on how we achieved our experimental results is shown in Figure 2. Four combinations were introduced into E.coli (BL21). Substrate (A) , substrate and our biobrick (A+B), substrate, our biobrick and GroE (A+B+C), substrate and GroE (A+C). | <h4>A simple explanation on how we achieved our experimental results is shown in Figure 2. Four combinations were introduced into E.coli (BL21). Substrate (A) , substrate and our biobrick (A+B), substrate, our biobrick and GroE (A+B+C), substrate and GroE (A+C). | ||
− | A can be either mNG-Aß1-42, EGFP-Aß1-42, α-synuclein-EGFP and Tau0N4R-EGFP. B is always pGroE7 and C is pSB4A5-GroES. | + | A can be either mNG-Aß1-42, EGFP-Aß1-42, α-synuclein-EGFP and Tau0N4R-EGFP. B is always pGroE7 and C is pSB4A5-GroES. |
− | + | ||
Bacteria containing plasmids were grown in LB- media containing antibiotic for respective plasmid until desired OD was achieved. The chaperones were induced with 0.25 mg/ml L-arabinose and 200 ng/ml tetracycline. For the substrate plasmids we used 0.5 mM IPTG, and the substrate was induced 30 mins after the chaperone plasmids. The bacterial samples were placed in a 96-well plate that ran for 16 hours in 37 °C in a Galaxy FLUOstar microplate reader. Measurements were conducted every 15 minutes. | Bacteria containing plasmids were grown in LB- media containing antibiotic for respective plasmid until desired OD was achieved. The chaperones were induced with 0.25 mg/ml L-arabinose and 200 ng/ml tetracycline. For the substrate plasmids we used 0.5 mM IPTG, and the substrate was induced 30 mins after the chaperone plasmids. The bacterial samples were placed in a 96-well plate that ran for 16 hours in 37 °C in a Galaxy FLUOstar microplate reader. Measurements were conducted every 15 minutes. | ||
</h4> | </h4> | ||
<img style="margin-bottom: 2px; margin-top:10px; border-radius: 8px" src="https://static.igem.org/mediawiki/parts/9/92/T--Linkoping_Sweden--expdesign.png"/> | <img style="margin-bottom: 2px; margin-top:10px; border-radius: 8px" src="https://static.igem.org/mediawiki/parts/9/92/T--Linkoping_Sweden--expdesign.png"/> | ||
− | <h4><i>Figure 2. | + | <h4><i>Figure 2. Illustrates the experimental procedure for our co-expression. The plasmids used are: Substrate plasmid (A), GroE7 from Takara (B) and GroES plasmid (C) </i> |
<h4/> | <h4/> | ||
<h2>Results</h2> | <h2>Results</h2> |
Revision as of 19:53, 17 October 2018